Shanghai, China

Yanxin Yu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Lianyungang, CN (2022)
  • Shanghai, CN (2021 - 2024)

Company Filing History:


Years Active: 2021-2024

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Innovator Spotlight: Yanxin Yu and His Contributions to HER2 Inhibitors

Introduction: Yanxin Yu is a renowned inventor based in Shanghai, China, who has made significant strides in the field of pharmaceuticals. With a total of five patents to his name, his work focuses on innovative compounds that offer selective inhibition of the HER2 target, promising advancements in cancer treatments.

Latest Patents: Among his notable inventions is the patent for Pyrrolo[2,1-f][1,2,4]triazine derivatives, which serve as selective HER2 inhibitors. This groundbreaking invention details a series of compounds represented by a specific formula that can be utilized in the preparation of drugs aimed at inhibiting HER2. Additionally, he has developed a crystallized form of a compound related to [1,2,4]triazolo[1,5-c]pyrimidine, which has shown potential for treating A-receptor related diseases, further emphasizing his contribution to medical science.

Career Highlights: Yanxin Yu has held prominent positions in influential companies within the pharmaceutical sector, including Medshine Discovery Inc. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Throughout his career, he has focused on innovative drug development and has contributed significantly to advancing pharmaceutical research.

Collaborations: Collaboration plays a crucial role in Yanxin Yu's work. He has partnered with esteemed colleagues such as Kevin X Chen and Fang Liu, a talented female scientist, further enriching his research and contributions to the field.

Conclusion: Yanxin Yu’s innovative patents and collaborations demonstrate his commitment to advancing medical science, particularly in the development of targeted cancer therapies. His work not only highlights his individual contributions but also reflects the importance of collaboration in achieving significant advancements in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…